Osteoporosis News

A recent report issued by the International Osteoporosis Foundation calls on physicians to recognize the signs of spinal fractures and cites figures that claim that as many as 65% of spinal fractures go undetected.

A daily dose of whole-body vibration may help reduce the usual bone density loss that occurs with age, according to findings recently published in Bone.

Osteoporosis Canada — an organization for those who have or are at risk for osteoporosis — has released comprehensive new guidelines aimed at preventing fragility fractures in women and men older than 50 years.

The use of parathyroid hormone prior to treatment by an antiresorptive drug, like alendronate, could be effective in the battle against osteoporosis, according to research published in the November issue of Cell Stem Cell.

TORONTO — New data reveal an association between oral bisphosphonate use and atypical subtrochanteric femoral fractures, researchers said at the American Society of Bone and Mineral Research 2010 Annual Meeting.

Since 2002, the U.S. Preventive Services Task Force has recommended that women ages 65 years and older be routinely screened for osteoporosis and has suggested that a 2-year screening interval might be appropriate. However, what length the screening interval should be is a topic that remains controversial and undecided, with no definitive scientific evidence to provide guidance.

A 6-week course of teriparatide, in conjunction with periodontal surgery, was associated with a greater resolution of osseous defects in patients with periodontal disease than placebo, according to the results of a Level 1 trial.

BALTIMORE — A study of bone biopsies taken from like-aged postmenopausal women undergoing internal fixation for femoral fractures has found that the women who had taken bisphosphonate treatments for osteoporosis had narrower pattern of aged bone matrix, perhaps indicating a loss of mechanical integrity.

The FDA today released a statement warning health care professionals and patients about the possible risk for atypical femoral fractures in patients who take bisphosphonates.

Preliminary findings contained in a soon to be released International Osteoporosis Foundation report highlight the poor state of post-fracture care in the region that includes the Russian Federation and other countries.